ScanNav anatomy PNB receives FDA approval | Popgen Tech
Intelligent Ultrasound, a company that develops software aimed at improving the quality, reliability and diagnostic power of medical ultrasounds, recently received de novo approval by the US Food and Drug Administration (FDA) for its ScanNav Anatomy PNB (peripheral nerve block) device.
ScanNav Anatomy PNB is a medical device and artificial intelligence (AI) powered system intended for use during regional anesthesia procedures. The device is designed to help healthcare professionals perform ultrasound-guided PNB and works by highlighting the live ultrasound image to help identify key anatomical structures while performing heart block procedures. peripheral nerves. ScanNav Anatomy PNB is designed to improve the accuracy of ultrasound imaging through a color overlay of key sono-anatomical structures during live ultrasound.
This device could be a game changer for PNB. With the AI assistant highlighting anatomical structures through ultrasound, PNB accuracy and ultimately safety can be greatly improved. ScanNav Anatomy PNB uses AI technology and will provide scan assessment of anatomical structures in the body by identifying and grading ultrasound images with deep learning technology.
ScanNav Anatomy PNB supports the following nine popular ultrasound-guided regional anesthesia procedures: Interscalene, Superior Trunk, Supraclavicular, Axillary, Erector Spinae Plane, Rectus Sheath, Suprainguinal Fascia Iliaca, Adductor Canal/Sub-sartorial femoral triangle, and Popliteal. In addition, the device is compatible with general purpose ultrasound machines with HDMI or DVI second monitor ports.
Since the FDA classified ScanNav Anatomy PNB under its de novo program, the agency concluded that there is no device already on the market that meets the clinical need, leading to the creation of a new generic type of anatomy visualization device classification in A real-time and labeling device for ultrasound-guided regional anesthesia.